InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,826.00
(
0.94%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
-0.64%
)
Bitcoin
56,730.16
(
-0.44%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

~MulaGreen~

Send PM Follow Ignore
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

~MulaGreen~

Re: ~MulaGreen~ post# 4160

Thursday, 05/20/2021 8:47:21 AM

Thursday, May 20, 2021 8:47:21 AM

Post# of 13742
Medolife is conducting clinical trials on Escozine(R) as a treatment for COVID-19 in both the United States and the DR.

The Company has completed an Investigational New Drug (IND) filing on Escozine(R) through the US Food and Drug Administration (FDA) and is awaiting a response after submission of its final data set.

Escozine(R) recently received renewed product registration in the DR, enabling it to be sold as a natural alternative medicine for the treatment of cancer throughout Latin America.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up